5-Alpha-Reductase Inhibitors for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Obstruction

November 2015 in “ Cochrane library ”

Herney Andrés García‐Perdomo, Hugo López-Ramos, James Tacklind

TLDR 5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

This protocol for a Cochrane Review aimed to evaluate the effectiveness of 5-alpha-reductase inhibitors (5ARIs) in treating lower urinary tract symptoms (LUTS) caused by benign prostatic obstruction (BPO).

View this study on cochranelibrary.com →

Discuss this study in the Community →

Related Research

3 / 3 results

research Most Recent Findings of Curative Drugs for Lower Urinary Tract Symptoms in Clinical Practice

January 2019 in “Nihon Yakuri Gakkai nenkai yoshishu”

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

research 5-Alpha-Reductase Inhibitors for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Obstruction

1 citations, November 2015 in “Cochrane library”

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

research Establishment of Type II 5α-Reductase Over-Expressing Cell Line as an Inhibitor Screening Model

12 citations, June 2007 in “Journal of steroid biochemistry and molecular biology/The Journal of steroid biochemistry and molecular biology”

A reliable model for screening type II 5α-reductase inhibitors was created and validated.